NO20070589L - Mitotiske kinesin-inhibitorer. - Google Patents
Mitotiske kinesin-inhibitorer.Info
- Publication number
- NO20070589L NO20070589L NO20070589A NO20070589A NO20070589L NO 20070589 L NO20070589 L NO 20070589L NO 20070589 A NO20070589 A NO 20070589A NO 20070589 A NO20070589 A NO 20070589A NO 20070589 L NO20070589 L NO 20070589L
- Authority
- NO
- Norway
- Prior art keywords
- mitotic kinesin
- kinesin inhibitors
- relates
- ksp kinesin
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Foreliggende oppfinnelse gjelder trisykliske pyrazoler ifølge formel (I) som er anvendbare for behandling av cellulære, proliferative sykdommer, for behandling av forstyrrelser forbundet med KSP-kinesinaktivitet og for inhibering av KSP-kinesin. Oppfinnelsen gjelder også preparater som omfatter disse forbindelsene og fremgangsmåter for anvendelse av dem for behandling av kreft i pattedyr.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58480804P | 2004-07-01 | 2004-07-01 | |
US60090104P | 2004-08-12 | 2004-08-12 | |
PCT/US2005/022730 WO2006007491A1 (en) | 2004-07-01 | 2005-06-27 | Mitotic kinesin inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070589L true NO20070589L (no) | 2007-03-22 |
Family
ID=35149059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070589A NO20070589L (no) | 2004-07-01 | 2007-01-31 | Mitotiske kinesin-inhibitorer. |
Country Status (15)
Country | Link |
---|---|
US (1) | US7632833B2 (no) |
EP (1) | EP1765830B1 (no) |
JP (1) | JP2008505085A (no) |
KR (1) | KR20070039885A (no) |
CN (1) | CN1980938B (no) |
AT (1) | ATE482218T1 (no) |
AU (1) | AU2005262373B2 (no) |
BR (1) | BRPI0512832A (no) |
CA (1) | CA2571807A1 (no) |
DE (1) | DE602005023730D1 (no) |
IL (1) | IL180328A0 (no) |
MX (1) | MXPA06015275A (no) |
NO (1) | NO20070589L (no) |
RU (1) | RU2007103816A (no) |
WO (1) | WO2006007491A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0818605A2 (pt) | 2007-10-19 | 2015-04-22 | Schering Corp | Derivados de 1,3,4-tiadiazl espiro-condensados para inibir a atividade de ksp cinesima |
NZ597833A (en) * | 2009-09-28 | 2014-01-31 | Hoffmann La Roche | Benzoxazepin pi3k inhibitor compounds and methods of use |
US20140087309A1 (en) * | 2011-04-01 | 2014-03-27 | The Research Foundation Of State University Of New York | Olefin-triggered acid amplifiers |
JP2014511849A (ja) * | 2011-04-01 | 2014-05-19 | ザ リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク | 安定化された酸増幅剤 |
US9453022B2 (en) | 2012-02-14 | 2016-09-27 | Children's Hospital Medical Center | Use of small molecule inhibitors targeting the interaction between Rac GTPase and p67 (phox) |
CA2909938A1 (en) * | 2013-04-22 | 2014-10-30 | Abbvie Inc. | Thiazoles and uses thereof |
CN108699080B (zh) * | 2016-02-23 | 2021-05-14 | 辉瑞公司 | 6,7-二氢-5H-吡唑并[5,1-b][1,3]噁嗪-2-甲酰胺化合物 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04501108A (ja) | 1988-09-22 | 1992-02-27 | イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー | 置換インダゾール殺節足動物剤 |
PH27357A (en) | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
US5719147A (en) | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
US5604260A (en) | 1992-12-11 | 1997-02-18 | Merck Frosst Canada Inc. | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
ATE160345T1 (de) | 1993-01-15 | 1997-12-15 | Searle & Co | 3,4-diarylthiophene und analoga davon, sowie deren verwendung als entzündungshemmende mittel |
US5409944A (en) | 1993-03-12 | 1995-04-25 | Merck Frosst Canada, Inc. | Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase |
US5380738A (en) | 1993-05-21 | 1995-01-10 | Monsanto Company | 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents |
US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
GB9602877D0 (en) | 1996-02-13 | 1996-04-10 | Merck Frosst Canada Inc | 3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors |
US5436265A (en) | 1993-11-12 | 1995-07-25 | Merck Frosst Canada, Inc. | 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents |
US5344991A (en) | 1993-10-29 | 1994-09-06 | G.D. Searle & Co. | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
US5466823A (en) | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5393790A (en) | 1994-02-10 | 1995-02-28 | G.D. Searle & Co. | Substituted spiro compounds for the treatment of inflammation |
US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
US6020343A (en) | 1995-10-13 | 2000-02-01 | Merck Frosst Canada, Inc. | (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
EP0892791B1 (en) | 1996-04-12 | 2003-03-05 | G.D. Searle & Co. | N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS |
US5861419A (en) | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
DE19805117A1 (de) | 1998-02-09 | 1999-08-12 | Bayer Ag | Neue Oxazolidinone mit azolhaltigen Tricyclen |
DE19905278A1 (de) | 1999-02-09 | 2000-08-10 | Bayer Ag | Oxazolidinone und ihre Verwendung als antibakterielle Mittel |
CA2467722A1 (en) * | 2001-12-06 | 2003-06-19 | Merck & Co., Inc. | Thienopyrimidinone derivatives as mitotic kinesin inhibitors |
AU2003249597B2 (en) | 2002-03-08 | 2007-06-28 | Merck Sharp & Dohme Corp. | Mitotic kinesin inhibitors |
-
2005
- 2005-06-27 DE DE602005023730T patent/DE602005023730D1/de active Active
- 2005-06-27 WO PCT/US2005/022730 patent/WO2006007491A1/en active Application Filing
- 2005-06-27 BR BRPI0512832-3A patent/BRPI0512832A/pt not_active Application Discontinuation
- 2005-06-27 RU RU2007103816/04A patent/RU2007103816A/ru unknown
- 2005-06-27 AT AT05786157T patent/ATE482218T1/de not_active IP Right Cessation
- 2005-06-27 CN CN2005800225786A patent/CN1980938B/zh not_active Expired - Fee Related
- 2005-06-27 KR KR1020067027736A patent/KR20070039885A/ko not_active Application Discontinuation
- 2005-06-27 MX MXPA06015275A patent/MXPA06015275A/es unknown
- 2005-06-27 JP JP2007519334A patent/JP2008505085A/ja active Pending
- 2005-06-27 EP EP05786157A patent/EP1765830B1/en active Active
- 2005-06-27 US US11/630,231 patent/US7632833B2/en not_active Expired - Fee Related
- 2005-06-27 AU AU2005262373A patent/AU2005262373B2/en not_active Ceased
- 2005-06-27 CA CA002571807A patent/CA2571807A1/en not_active Abandoned
-
2006
- 2006-12-25 IL IL180328A patent/IL180328A0/en unknown
-
2007
- 2007-01-31 NO NO20070589A patent/NO20070589L/no unknown
Also Published As
Publication number | Publication date |
---|---|
US20080287414A1 (en) | 2008-11-20 |
CA2571807A1 (en) | 2006-01-19 |
BRPI0512832A (pt) | 2008-04-08 |
IL180328A0 (en) | 2007-07-04 |
AU2005262373A1 (en) | 2006-01-19 |
MXPA06015275A (es) | 2007-03-15 |
EP1765830B1 (en) | 2010-09-22 |
KR20070039885A (ko) | 2007-04-13 |
AU2005262373B2 (en) | 2011-03-17 |
ATE482218T1 (de) | 2010-10-15 |
CN1980938A (zh) | 2007-06-13 |
CN1980938B (zh) | 2010-11-03 |
JP2008505085A (ja) | 2008-02-21 |
WO2006007491A1 (en) | 2006-01-19 |
RU2007103816A (ru) | 2008-08-10 |
US7632833B2 (en) | 2009-12-15 |
EP1765830A1 (en) | 2007-03-28 |
DE602005023730D1 (de) | 2010-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE448207T1 (de) | Mitotische kinesin-hemmer | |
ATE446094T1 (de) | Mitotische kinesin-hemmer | |
DK1664026T3 (da) | Inhibitorer af mitotisk kinesin | |
ATE424388T1 (de) | Mitotische kinesinhemmer | |
ATE447577T1 (de) | Mitotische kinesin-hemmer | |
DE60312516D1 (de) | Inhibitoren von mitotischem kinesin | |
ATE372341T1 (de) | Inhibitoren von mitotischem kinesin | |
WO2006068933A3 (en) | Mitotic kinesin inhibitors | |
WO2006086358A3 (en) | Mitotic kinesin inhibitors | |
WO2006078574A3 (en) | Mitotic kinesin inhibitors | |
WO2006031348A3 (en) | Mitotic kinesin inhibitors | |
WO2006078598A3 (en) | Mitotic kinesin inhibitors | |
WO2006007496A3 (en) | Mitotic kinesin inhibitors | |
NO20070589L (no) | Mitotiske kinesin-inhibitorer. | |
WO2006007501A3 (en) | Mitotic kinesin inhibitors | |
WO2006101761A3 (en) | Mitotic kinesin inhibitors | |
WO2006023440A3 (en) | Mitotic kinesin inhibitors | |
ATE426605T1 (de) | Inhibitoren von mitotischem kinesin | |
WO2005060654A3 (en) | Mitotic kinesin inhibitors | |
WO2006007497A3 (en) | Prodrugs of mitotic kinesin inhibitors | |
WO2004087050A3 (en) | Mitotic kinesin inhibitors |